M&A Deal Summary |
|
|---|---|
| Date | 2009-10-12 |
| Target | Diatos - Vectocell Technology |
| Sector | Medical Products |
| Buyer(s) | Cellectis |
| Sellers(s) | DIATOS S.A. |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
| Employees | 203 |
| Revenue | 50M EUR (2015) |
Cellectis is a gene-editing company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART). Cellectis was founded in 1999 and is based in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Medical Products M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2009 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-09 |
Cyto Pulse Sciences
Glen Burnie, Maryland, United States Cyto Pulse Sciences specializing in the development, manufacture and commercialization of electroporation technology and equipment. |
Buy | $2M |
Diatos S.A., a biopharmaceutical company, focuses on the research, development, and commercialization of targeted anti-cancer drugs.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2009 M&A | 1 of 1 |
